跳至主要内容
临床试验/NCT00873379
NCT00873379已完成3 期

Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly: a Randomized, Double Blind, Placebo-Controlled Trial

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2007年10月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
122
试验地点
1
主要终点
delirious using confusion assessment method (CAM)

研究概览

简要总结

122 people over 70 who were admitted to hospital were enrolled to the study. Half got .5 mg a night of melatonin, half got a placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age over 65 admitted through the emergency department to an internal medicine service in London, Ontario, Canada.

排除标准

  • •Life expectancy less than 24 hours,
  • •Unable to communicate in English,
  • •Unable to take oral medications,
  • •Intracranial bleed or known seizure disorder,
  • •Markedly sub or supra-therapeutic INR while on warfarin, OR
  • •A known allergy to study tablet ingredients.

研究组 & 干预措施

placebo

Placebo Comparator

half a white placebo tablet

干预措施: placebo (Dietary Supplement)

melatonin

Active Comparator

.5 mg (one half of a 1 mg tablet of GNC rapid dissolving Melatonin, natural product number (NPN) 80001380)

干预措施: melatonin (Dietary Supplement)

结局指标

主要结局

delirious using confusion assessment method (CAM)

时间窗: days

次要结局

  • MDAS (memorial delirium assessment scale)(days)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验